Neuromodulation Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuromodulation stocks.

Neuromodulation Stocks Recent News

Date Stock Title
May 31 BSX Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
May 31 BSX Envista (NVST) Down 4.7% Since Last Earnings Report: Can It Rebound?
May 31 BSX Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M
May 31 BSX DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?
May 31 BSX Veeva Systems (VEEV) Q1 Earnings Beat Estimates, Margins Up
May 30 BSX Here's Why You Should Add Lantheus (LNTH) to Your Portfolio Now
May 30 BSX Stryker (SYK) to Launch Gamma4 Hip Fracture System in Europe
May 30 BSX Reasons Why You Should Retain Avantor (AVTR) Stock for Now
May 30 ECOR Wall Street Analysts See a 251.77% Upside in electroCore (ECOR): Can the Stock Really Move This High?
May 29 BSX Stryker (SYK) Issues Safety Notice for Its Total Knee System
May 29 BSX Reasons to Retain PacBio (PACB) Stock in Your Portfolio
May 29 ECOR Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer
May 28 BSX Intuitive Surgical Stock Gains 20% YTD: Here's Why
May 28 BSX Intuitive Surgical (ISRG) Stock Gains 20% YTD: Here's Why
May 27 BSX HAE or BSX: Which Is the Better Value Stock Right Now?
May 27 BSX ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?
May 27 BSX Inari Medical (NARI) Sues Truvic on Patent Infringement
May 27 ZYXI Should Value Investors Buy Zynex (ZYXI) Stock?
May 27 BSX Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
May 27 NPCE NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions
Neuromodulation

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. This is in contrast to synaptic transmission in which an axonal terminal secretes neurotransmitters to target fast-acting receptors of only one particular partner neuron. Neuromodulators are neurotransmitters that diffuse through neural tissue to affect slow-acting receptors of many neurons. Major neuromodulators in the central nervous system include dopamine, serotonin, acetylcholine, histamine, and norepinephrine. Neuromodulators are known to have modulatory effects on target areas such as decorrelation of spiking, increase of firing rate, sharpening of spatial tuning curves, maintenance of increased spiking during working memory.A neuromodulator can be conceptualized as a neurotransmitter that is not reabsorbed by the pre-synaptic neuron or broken down into a metabolite. Such neuromodulators end up spending a significant amount of time in the cerebrospinal fluid (CSF), influencing (or "modulating") the activity of several other neurons in the brain. For this reason, some neurotransmitters are also considered to be neuromodulators, such as serotonin and acetylcholine.Neuromodulation is often contrasted with classical fast synaptic transmission. In both cases the transmitter acts on local postsynaptic receptors, but in neuromodulation, the receptors are typically G-protein coupled receptors while in classical chemical neurotransmission, they are ligand-gated ion channels. Neurotransmission that involves metabotropic receptors (like G-protein linked receptors) often also involves voltage-gated ion channels, and is relatively slow. Conversely, neurotransmission that involves exclusively ligand-gated ion channels is much faster.
A related distinction is also sometimes drawn between modulator and driver synaptic inputs to a neuron, but here the emphasis is on modulating ongoing neuronal spiking versus causing that spiking.

Browse All Tags